Quarterly report pursuant to Section 13 or 15(d)

Note 13 - (Loss) Income Per Share (Details Textual)

v3.22.2.2
Note 13 - (Loss) Income Per Share (Details Textual) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares)   672,373  
Share-Based Payment Arrangement, Option [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 437,352   570,090
Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 0   150,000